Alzheimer Disease

Contributing journals to this collection:
JAMA & Archives Journals

Citations 271-280 of 695 total displayed.

Past content

Original Contributions
Magnetoencephalographic Parietal Dipole Density in Mild Cognitive Impairment: Preliminary Results of a Method to Estimate the Risk of Developing Alzheimer Disease

Alberto Fernández; Agustín Turrero; Pilar Zuluaga; Pedro Gil; Fernando Maestú; Pablo Campo; Tomás Ortiz
Arch Neurol 2006; 63: 427-430. [Abstract] [Full text] [PDF]  

Original Contributions
Association of Apolipoprotein E Genotype and Alzheimer Disease in African Americans

Jill R. Murrell; Brandon Price; Kathleen A. Lane; Olusegun Baiyewu; Oye Gureje; Adesola Ogunniyi; Frederick W. Unverzagt; Valerie Smith-Gamble; Sujuan Gao; Hugh C. Hendrie; Kathleen S. Hall
Arch Neurol 2006; 63: 431-434. [Abstract] [Full text] [PDF]  

Original Articles
Increased Hippocampal Plaques and Tangles in Patients With Alzheimer Disease With a Lifetime History of Major Depression

Michael A. Rapp; Michal Schnaider-Beeri; Hillel T. Grossman; Mary Sano; Daniel P. Perl; Dushyant P. Purohit; Jack M. Gorman; Vahram Haroutunian
Arch Gen Psychiatry 2006; 63: 161-167. [Abstract] [Full text] [PDF]  

Original Articles
Role of Genes and Environments for Explaining Alzheimer Disease

Margaret Gatz; Chandra A. Reynolds; Laura Fratiglioni; Boo Johansson; James A. Mortimer; Stig Berg; Amy Fiske; Nancy L. Pedersen
Arch Gen Psychiatry 2006; 63: 168-174. [Abstract] [Full text] [PDF]  

Clinical Trials
Effects of Testosterone on Cognition and Mood in Male Patients With Mild Alzheimer Disease and Healthy Elderly Men

Po H. Lu; Donna A. Masterman; Ruth Mulnard; Carl Cotman; Bruce Miller; Kristine Yaffe; Erin Reback; Verna Porter; Ronald Swerdloff; Jeffrey L. Cummings
Arch Neurol 2006; 63: 177-185. [Abstract] [Full text] [PDF]  

Original Contributions
Relation of Quantitative Indexes of Concurrent -Synuclein Abnormalities to Clinical Outcome in Autopsy-Proven Alzheimer Disease

Roee Holtzer; Michael C. Irizarry; Jody Sanders; Bradley T. Hyman; Domonick J. Wegesin; Aliza Riba; Jason Brandt; Marilyn Albert; Yaakov Stern
Arch Neurol 2006; 63: 226-230. [Abstract] [Full text] [PDF]  

Editorials
Mild Cognitive Impairment Is Early-Stage Alzheimer Disease: Time to Revise Diagnostic Criteria

John C. Morris
Arch Neurol 2006; 63: 15-16. [Extract] [Full text] [PDF]  

Editorials
What We Can Learn From Open-Label Extensions of Randomized Clinical Trials

Jeffrey L. Cummings
Arch Neurol 2006; 63: 18-19. [Extract] [Full text] [PDF]  

Original Contributions
Neuropathologic Substrate of Mild Cognitive Impairment

William R. Markesbery; Frederick A. Schmitt; Richard J. Kryscio; Daron G. Davis; Charles D. Smith; David R. Wekstein
Arch Neurol 2006; 63: 38-46. [Abstract] [Full text] [PDF]  

Original Contributions
A 24-Week Open-Label Extension Study of Memantine in Moderate to Severe Alzheimer Disease

Barry Reisberg; Rachelle Doody; Albrecht Stöffler; Frederick Schmitt; Steven Ferris; Hans Jörg Möbius
Arch Neurol 2006; 63: 49-54. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70